In addition to antagonizing inflammation by inhibit- ing the activity of cyclooxygenases (COX), nonsteroidal anti-inflammatory drugs (NSAID) block T-cell activa- tion. The immunosuppressant activity of NSAID corre- lates with their ability to block transcription factors required for the expression of inducible response genes triggered by T-cell antigen receptor (TCR) engagement. Whereas the inhibition of nuclear factor-B by aspirin and sodium salicylate can be partly accounted for by their binding to IB kinase-, the broad range of tran- scriptional targets of NSAID suggests that the products of COX activity might affect one or more among the early steps in the TCR-signaling cascade. Here we show that the inhibition of NF-AT activation by NSAID corre- lates with a selective inhibition of p38 MAP kinase in- duction. The suppression of TCR-dependent p38 activa- tion by NSAID can be fully overcome by prostaglandin E2, underlining the requirement for COX activity in p38 activation. Furthermore, the inhibition of COX-1 results in defective induction of the COX-2 gene, which behaves as an early TCR responsive gene. The data identify COX-1 and COX-2 as integral and sequential components of TCR signaling to p38 and contribute to elucidate the molecular basis of immunosuppression by NSAID.

ROSSI PACCANI, S., Boncristiano, M., Ulivieri, C., D' ELIOS, M.m., DEL PRETE, G., Baldari, C. (2002). Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAP kinase induction. THE JOURNAL OF BIOLOGICAL CHEMISTRY, 277(2), 1509-1513 [10.1074/jbc.M110676200].

Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAP kinase induction

ROSSI PACCANI, SILVIA;ULIVIERI, CRISTINA;D' ELIOS MM;BALDARI, COSIMA
2002-01-01

Abstract

In addition to antagonizing inflammation by inhibit- ing the activity of cyclooxygenases (COX), nonsteroidal anti-inflammatory drugs (NSAID) block T-cell activa- tion. The immunosuppressant activity of NSAID corre- lates with their ability to block transcription factors required for the expression of inducible response genes triggered by T-cell antigen receptor (TCR) engagement. Whereas the inhibition of nuclear factor-B by aspirin and sodium salicylate can be partly accounted for by their binding to IB kinase-, the broad range of tran- scriptional targets of NSAID suggests that the products of COX activity might affect one or more among the early steps in the TCR-signaling cascade. Here we show that the inhibition of NF-AT activation by NSAID corre- lates with a selective inhibition of p38 MAP kinase in- duction. The suppression of TCR-dependent p38 activa- tion by NSAID can be fully overcome by prostaglandin E2, underlining the requirement for COX activity in p38 activation. Furthermore, the inhibition of COX-1 results in defective induction of the COX-2 gene, which behaves as an early TCR responsive gene. The data identify COX-1 and COX-2 as integral and sequential components of TCR signaling to p38 and contribute to elucidate the molecular basis of immunosuppression by NSAID.
2002
ROSSI PACCANI, S., Boncristiano, M., Ulivieri, C., D' ELIOS, M.m., DEL PRETE, G., Baldari, C. (2002). Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAP kinase induction. THE JOURNAL OF BIOLOGICAL CHEMISTRY, 277(2), 1509-1513 [10.1074/jbc.M110676200].
File in questo prodotto:
File Dimensione Formato  
Paccani et al JBC 2002.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 205.12 kB
Formato Adobe PDF
205.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/21927
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo